Tolemy Bio
PrivateLast Round
Pre Seed
May 12, 2026
Total Funding Raised
$1.4M
Momentum Score
25 /100
Company Overview
Tolemy Bio is a biotechnology company that develops an AI-native platform, Orbit, to help biopharma teams interpret, optimize, and control cell-based therapeutic processes for drug development and manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, ML Platforms, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tolemy Bio Comps
Public and private peers based on sector, stage, and business model.
Tolemy Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 12, 2026 |
Tolemy Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redbus Group | Pre Seed |
| JME Venture Capital | Pre Seed |
| Masia | Pre Seed |
| Norrsken Evolve | Pre Seed |
| Big Sur Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
$2M round led by Norrsken Evolve.
- Apr 16, 2026
Monthly visitors grew 98% MoM, reaching 1.1K.
Tolemy Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tolemy Bio's valuation, stock price, and market status.
